Possible Role of Organic Cation Transporters in the Distribution of [11C]Sulpiride, a Dopamine D2 Receptor Antagonist.

[1]  S. Jakobsen,et al.  In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses , 2016, The Journal of Nuclear Medicine.

[2]  Joanne Wang,et al.  Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. , 2016, Pharmacological research.

[3]  S. Jakobsen,et al.  [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency , 2016, Diabetes.

[4]  H. Koepsell.  Role of organic cation transporters in drug–drug interaction , 2015, Expert opinion on drug metabolism & toxicology.

[5]  Yasuyoshi Watanabe,et al.  Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [11C]Metformin in Mouse , 2015, Pharmaceutical Research.

[6]  Yasuyoshi Watanabe,et al.  The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo. , 2013, Bioorganic & medicinal chemistry.

[7]  H. Kusuhara,et al.  Imaging in the Study of Membrane Transporters , 2013, Clinical pharmacology and therapeutics.

[8]  K. Inui,et al.  Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney , 2013, The AAPS Journal.

[9]  Kazuya Maeda,et al.  PET Imaging–Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-Me , 2012, The Journal of Nuclear Medicine.

[10]  H. Kusuhara,et al.  Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney , 2012, Journal of Pharmacology and Experimental Therapeutics.

[11]  Paul M. Matthews,et al.  Positron emission tomography molecular imaging for drug development. , 2012, British journal of clinical pharmacology.

[12]  Y Kumagai,et al.  Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects , 2011, Clinical pharmacology and therapeutics.

[13]  K. Park,et al.  Rifampin Enhances the Glucose‐Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants , 2011, Clinical pharmacology and therapeutics.

[14]  H. Kusuhara,et al.  Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine , 2010, Journal of Pharmacology and Experimental Therapeutics.

[15]  Hidehiko Takahashi,et al.  Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. , 2010, The Journal of clinical psychiatry.

[16]  Hiroaki Yuasa,et al.  The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine , 2009, Drug Metabolism and Disposition.

[17]  F. Yasuno,et al.  The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride. , 2006, The international journal of neuropsychopharmacology.

[18]  R. Neubert,et al.  Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). , 2005, Biochemical pharmacology.

[19]  K. Maeda,et al.  Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.

[20]  A. Schinkel,et al.  Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.

[21]  F. Lang,et al.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.

[22]  Sulpiride , 2018, Reactions Weekly.

[23]  P. Benfield,et al.  Sulpiride , 1994 .

[24]  R. Gomeni,et al.  Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels. , 1984, Journal of pharmaceutical sciences.

[25]  G. Sedvall,et al.  The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects , 1980, European Journal of Clinical Pharmacology.

[26]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[27]  T Nakagawa,et al.  A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.